Washington, Oct. 6, 2025: Brownstein Hyatt Farber Schreck is pleased to announce that Karla Arias has joined the firm’s Washington, D.C. office as of counsel in the Intellectual Property Department. She brings expertise in patent and trade secret litigation, as well as patent prosecution for clients in the chemical and pharmaceutical industries.
“Bringing Karla on board is a key step in our ongoing commitment to deepening our bench in high-stakes intellectual property matters,” said Airina Rodrigues, cochair of the firm’s IP Department. “Her unique combination of scientific rigor and legal insight will be an incredible asset to our
clients, particularly those in the chemical and pharmaceutical sectors.”
Arias joins the firm from Crowell & Moring LLP, where she served as counsel in the Washington, D.C. office. Her extensive scientific background and legal acumen make her a valuable addition to the Brownstein team. Prior to her legal career, Arias was a postdoctoral fellow at Carnegie Mellon University, where she researched the degradation of endocrine-disrupting contaminants in water and the formation and reactivity of iron complexes.
She earned her doctorate in organic chemistry from the University of Zurich, focusing on the synthesis of supramolecular architectures and the study of fluorescent and phosphorescent properties of supramolecular building blocks. She also earned her J.D. from George Mason University and her bachelor’s degree from the University of California, San Diego.
About Brownstein Hyatt Farber Schreck, LLP:
At Brownstein, clients get access to the top legal minds in the industry, powerful policy knowledge and best-in-class business acumen to solve businesses’ toughest challenges. Brownstein is a law and lobbying firm that has been making moves for more than 50 years to stay at the vanguard of its industry. You’ll find this firm at the heart of many of the most important cases, the most significant deals and the country’s most pivotal legislation. Brownstein—we’re all in. For more information, visit us at bhfs.com.

Join the Discussion
No comments yet.